Mutations that only occur in some brain cells may account for a significant fraction of specific types of epilepsy, according to a new Columbia study.
Scientists propose a new model for Alzheimer's disease that may explain the high failure rate of recent clinical trials.
A cellular defense against protein aggregates suppresses ALS in early stages but later hastens spread of the disease, a study in mice suggests.
Age-related memory loss was reversed by boosting blood levels of osteocalcin, a hormone produced by bone cells, in mice.
Memories "lost" to Alzheimer's disease may just be hard to retrieve, suggests a new study by neuroscientists at Columbia University Medical Center.
Columbia neurologist Denise Chou, MD, explains a new breakthrough in headache medicine: the first targeted preventive therapy for migraine.